1. Kim TY, Rhee JE, Kim KS, Cha WC, Suh GJ, Jung SK. Etomidate should be used carefully for emergent endotracheal intubation in patients with septic shock. J Korean Med Sci. 2008. 23:988–991.
Article
2. Hildreth AN, Mejia VA, Maxwell RA, Smith PW, Dart BW, Barker DE. Adrenal suppression following a single dose of etomidate for rapid sequence induction: a prospective randomized study. J Trauma. 2008. 65:573–579.
Article
3. Tekwani KL, Watts HF, Rzechula KH, Sweis RT, Kulstad EB. A prospective observational study of the effect of etomidate on septic patient mortality and length of stay. Acad Emerg Med. 2009. 16:11–14.
Article
4. Zed PJ, Mabasa VH, Slavik RS, Abu-Laban RB. Etomidate for rapid sequence intubation in the emergency department: is adrenal suppression a concern? CJEM. 2006. 8:347–350.
Article
5. Walls RM, Murphy MF. Clinical controversies: etomidate as an induction agent for endotracheal intubation in patients with sepsis: continue to use etomidate for intubation of patients with septic shock. Ann Emerg Med. 2008. 52:13–14.
6. Sacchetti A. Etomidate: not worth the risk in septic patients. Ann Emerg Med. 2008. 52:14–16.
Article
7. Jackson WL Jr. Should we use etomidate as an induction agent for endotracheal intubation in patients with septic shock? a critical appraisal. Chest. 2005. 127:1031–1038.
8. Annane D. ICU physicians should abandon the use of etomidate! Intensive Care Med. 2005. 31:325–326.
Article
9. Vinclair M, Broux C, Faure P, Brun J, Genty C, Jacquot C, Chabre O, Payen JF. Duration of adrenal inhibition following a single dose of etomidate in critically ill patients. Intensive Care Med. 2008. 34:714–719.